White House officials on Tuesday dismissed a report that speculated that President Trump had gained access to the weight loss drug retrecutide under the Food and Drug Administration’s (FDA) “compassionate use program.” The drug Rettrutide is manufactured by Eli Lilly and is not approved by the FDA, however, one person gained access to a prescription through a program…
Please follow and like us:
